1: Turski CA, Turski GN, Chen B, Wang H, Heidari M, Li L, Noguchi KK, Westmark C, Duncan I, Ikonomidou C. Clemastine effects in rat models of a myelination disorder. Pediatr Res. 2018 May 2. doi: 10.1038/pr.2018.45. [Epub ahead of print] PubMed PMID: 29584714.
2: Domagała A, Szepietowski J, Reich A. Antihistamines in the treatment of pruritus in psoriasis. Postepy Dermatol Alergol. 2017 Oct;34(5):457-463. doi: 10.5114/ada.2017.71112. Epub 2017 Oct 31. PubMed PMID: 29507561; PubMed Central PMCID: PMC5831281.
3: Magno Pereira V, Andrade C, Figueira R, Faria G, Jasmins L. Infliximab-Induced Lupus: A Case Report. GE Port J Gastroenterol. 2017 Mar;24(2):84-88. doi: 10.1159/000450877. Epub 2016 Nov 19. PubMed PMID: 29255743; PubMed Central PMCID: PMC5729968.
4: Cree BAC, Niu J, Hoi KK, Zhao C, Caganap SD, Henry RG, Dao DQ, Zollinger DR, Mei F, Shen YA, Franklin RJM, Ullian EM, Xiao L, Chan JR, Fancy SPJ. Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury. Brain. 2018 Jan 1;141(1):85-98. doi: 10.1093/brain/awx312. PubMed PMID: 29244098.
5: Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR. Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10. PubMed PMID: 29029896.
6: Cohen JA, Tesar PJ. Clemastine fumarate for promotion of optic nerve remyelination. Lancet. 2017 Dec 2;390(10111):2421-2422. doi: 10.1016/S0140-6736(17)32639-9. Epub 2017 Oct 10. PubMed PMID: 29029894.
7: Bove RM, Green AJ. Remyelinating Pharmacotherapies in Multiple Sclerosis. Neurotherapeutics. 2017 Oct;14(4):894-904. doi: 10.1007/s13311-017-0577-0. Review. PubMed PMID: 28948533; PubMed Central PMCID: PMC5722779.
8: Yildirim A, Lübbers HT, Yildirim A. Anaphylaxie induite par des médicaments. Swiss Dent J. 2017;127(4):324-325. French. PubMed PMID: 28480948.
9: Nicaise AM, Banda E, Guzzo RM, Russomanno K, Castro-Borrero W, Willis CM, Johnson KM, Lo AC, Crocker SJ. iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response. Exp Neurol. 2017 Feb;288:114-121. doi: 10.1016/j.expneurol.2016.11.012. Epub 2016 Nov 16. PubMed PMID: 27865736.
10: Zada D, Tovin A, Lerer-Goldshtein T, Appelbaum L. Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish. Dis Model Mech. 2016 Nov 1;9(11):1339-1348. Epub 2016 Sep 23. PubMed PMID: 27664134; PubMed Central PMCID: PMC5117236.
11: Apolloni S, Fabbrizio P, Amadio S, Volonté C. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression. J Neuroinflammation. 2016 Aug 22;13(1):191. doi: 10.1186/s12974-016-0658-8. PubMed PMID: 27549088; PubMed Central PMCID: PMC4994328.
12: Abbasi MM, Valizadeh H, Hamishekar H, Mohammadnejad L, Zakeri-Milani P. Inhibitory effect of clemastine on P-glycoprotein expression and function: an in vitro and in situ study. Iran J Basic Med Sci. 2016 Apr;19(4):423-9. PubMed PMID: 27279987; PubMed Central PMCID: PMC4887716.
13: De Rycker M, Thomas J, Riley J, Brough SJ, Miles TJ, Gray DW. Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade. PLoS Negl Trop Dis. 2016 Apr 15;10(4):e0004584. doi: 10.1371/journal.pntd.0004584. eCollection 2016 Apr. PubMed PMID: 27082760; PubMed Central PMCID: PMC4833300.
14: Desar IM, van Herpen CM, van Erp NP, Kaal SE, van de Kerkhof PC, van der Graaf WT. A successful approach to overcome imatinib-induced skin toxicity in a GIST patient. Anticancer Drugs. 2016 Jul;27(6):576-9. doi: 10.1097/CAD.0000000000000359. PubMed PMID: 26982239.
15: Liu J, Dupree JL, Gacias M, Frawley R, Sikder T, Naik P, Casaccia P. Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice. J Neurosci. 2016 Jan 20;36(3):957-62. doi: 10.1523/JNEUROSCI.3608-15.2016. PubMed PMID: 26791223; PubMed Central PMCID: PMC4719024.
16: Zawrotniak M, Kozik A, Rapala-Kozik M. Selected mucolytic, anti-inflammatory and cardiovascular drugs change the ability of neutrophils to form extracellular traps (NETs). Acta Biochim Pol. 2015;62(3):465-73. doi: 10.18388/abp.2015_1055. Epub 2015 Aug 20. PubMed PMID: 26291043.
17: Li Z, He Y, Fan S, Sun B. Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination. Neurosci Bull. 2015 Oct;31(5):617-25. doi: 10.1007/s12264-015-1555-3. Epub 2015 Aug 6. PubMed PMID: 26253956; PubMed Central PMCID: PMC5563681.
18: Lee SY, Jung JW, Kim TH, Kim HD. Asymmetric synthesis of H1 receptor antagonist (R,R)-clemastine. Arch Pharm Res. 2015 Dec;38(12):2131-6. doi: 10.1007/s12272-015-0641-4. Epub 2015 Jul 29. PubMed PMID: 26219510.
19: Strassen U, Bas M, Hoffmann TK, Knopf A, Greve J. Treatment of angiotensin receptor blocker-induced angioedema: A case series. Laryngoscope. 2015 Jul;125(7):1619-23. doi: 10.1002/lary.25163. Epub 2015 Feb 3. PubMed PMID: 25646708.
20: Baş M, Greve J, Stelter K, Havel M, Strassen U, Rotter N, Veit J, Schossow B, Hapfelmeier A, Kehl V, Kojda G, Hoffmann TK. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015 Jan 29;372(5):418-25. doi: 10.1056/NEJMoa1312524. PubMed PMID: 25629740.